Delivery Order SPE2DB20D2014-SPE2DB25FD12L
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (quantity 90) with a ceiling value of $1,558.90. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, under a firm fixed-price contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performed the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Irbesartan 150 mg tablets in quantities of 90 units, with a contract ceiling value of $2,260.39. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a $5,160.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Irbesartan 150 mg on August 11, 2025, with completion due by August 12, 2025. This contract was competitively awarded with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $2,035.92 to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (90-count) on September 16, 2025, with completion anticipated by September 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of a generic antihypertensive medication to support federal healthcare operations. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Irbesartan 75 mg tablets in a quantity of 90 units, with a ceiling value of $5,990.86. This contract, classified as a firm fixed price delivery order with no set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $1,357.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Irbesartan 75 mg tablets in quantities of 90 units. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,867.88, is for the delivery of Irbesartan 150 mg tablets. It is a firm fixed-price contract with an ultimate completion date of May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,993.00 firm fixed-price delivery order contract is for the supply of Irbesartan 150 mg tablets to support military healthcare programs. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $3,330 delivery order to Amerisourcebergen Drug Corporation for Irbesartan 75 mg tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 90 tablets of the hypertension medication to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 defense contractor, Amerisourcebergen frequently provides pharmaceuticals and medical supplies to the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.89 firm fixed-price delivery order is for the supply of Irbesartan 150 mg tablets. The contract has a period of performance through November 12, 2024 and does not include any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD12LDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,776.40 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Irbesartan 150 mg tablets (90-count packaging). This competitive award utilizes firm fixed pricing with an ultimate completion date of September 26, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's contract portfolio demonstrates extensive experience fulfilling federal medical supply requirements across multiple therapeutic domains, positioning it to support the Defense Health Agency and other government healthcare systems through flexible, comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/25/25 |